By Chelsea Naso ( November 20, 2018, 1:44 PM EST) -- Massachusetts-based Boston Scientific Corp., led by Shearman & Sterling LLP, unveiled plans Tuesday to shell out £3.3 billion ($4.2 billion) for U.K.-based BTG PLC, which makes medical devices for the treatment of cancer and vascular disease....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.